Sebum production pathways

Sebum production pathways encompass the integrated network of biochemical and cellular processes within sebocytes that lead to the synthesis and secretion of sebum [1.4.1, 1.4.2]. This process is primarily regulated by androgen signaling, where dihydrotestosterone (DHT) binds to androgen receptors to upregulate lipogenic gene expression [1.1.1, 1.3.2]. Key enzymatic regulators include 5-alpha reductase, which converts testosterone to DHT, and acetyl-CoA carboxylase (ACC), which catalyzes the rate-limiting step in fatty acid synthesis [1.2.3, 1.2.4]. Additionally, nuclear receptors such as PPAR-gamma and transcription factors like SREBP-1 play pivotal roles in coordinating the production of sebum-specific lipids, including squalene and wax esters [1.3.1, 1.4.3]. Dysregulation of these pathways, particularly hyperseborrhea, is a central factor in the pathogenesis of acne vulgaris [1.1.2, 1.3.3]. Therapeutic strategies target various nodes within these pathways, ranging from hormonal modulation with clascoterone or spironolactone to the profound suppression of sebocyte activity by oral isotretinoin [1.1.1, 1.1.5]. While 'Sebum production pathways' describes a critical biological process, it is not a single molecular target but rather a collection of pathways involving multiple receptors and enzymes [1.4.1]. Understanding these pathways is essential for developing targeted dermatological treatments that balance skin barrier function with the prevention of inflammatory lesions [1.2.1, 1.4.1].

Other names

Sebogenesis pathwaysSebaceous gland lipogenesisSebum synthesis pathwaysSebocyte lipid production

Inhibition of androgen signaling, modulation of retinoid receptors to induce sebocyte apoptosis, and inhibition of lipogenic enzymes such as acetyl-CoA carboxylase to reduce fatty acid synthesis.